185 related articles for article (PubMed ID: 32728410)
1. GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition.
Bestion E; Jilkova ZM; Mège JL; Novello M; Kurma K; Pour STA; Lalmanach G; Vanderlynden L; Fizanne L; Bassissi F; Rachid M; Tracz J; Boursier J; Courcambeck J; Serdjebi C; Ansaldi C; Decaens T; Halfon P; Brun S
Ther Adv Chronic Dis; 2020; 11():2040622320942042. PubMed ID: 32728410
[TBL] [Abstract][Full Text] [Related]
2. Honokiol Acts as a Potent Anti-Fibrotic Agent in the Liver through Inhibition of TGF-β1/SMAD Signaling and Autophagy in Hepatic Stellate Cells.
Kataoka S; Umemura A; Okuda K; Taketani H; Seko Y; Nishikawa T; Yamaguchi K; Moriguchi M; Kanbara Y; Arbiser JL; Shima T; Okanoue T; Itoh Y
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948151
[TBL] [Abstract][Full Text] [Related]
3. Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo/Yap and TGF-β1/Smad signaling.
Perumal N; Perumal M; Halagowder D; Sivasithamparam N
Biochimie; 2017 Sep; 140():10-19. PubMed ID: 28552397
[TBL] [Abstract][Full Text] [Related]
4. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
5. Thymosin β4 suppresses CCl
Li H; Li Q; Zhang X; Zheng X; Zhang Q; Hao Z
J Gene Med; 2018 Sep; 20(9):e3043. PubMed ID: 29972714
[TBL] [Abstract][Full Text] [Related]
6. Anti-fibrotic Effects of Synthetic Oligodeoxynucleotide for TGF-β1 and Smad in an Animal Model of Liver Cirrhosis.
Kim JY; An HJ; Kim WH; Gwon MG; Gu H; Park YY; Park KK
Mol Ther Nucleic Acids; 2017 Sep; 8():250-263. PubMed ID: 28918026
[TBL] [Abstract][Full Text] [Related]
7. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J
Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197
[TBL] [Abstract][Full Text] [Related]
8. Development of a Chimeric Protein BiPPB-mIFNγ-tTβRII for Improving the Anti-Fibrotic Activity in Vivo by Targeting Fibrotic Liver and Dual Inhibiting the TGF-β1/Smad Signaling Pathway.
Dong Y; Wang X; Xu L; Li X; Dai H; Mao X; Chu Y; Yuan X; Liu H
Protein J; 2023 Dec; 42(6):753-765. PubMed ID: 37690089
[TBL] [Abstract][Full Text] [Related]
9. RNA sequencing of LX-2 cells treated with TGF-β1 identifies genes associated with hepatic stellate cell activation.
Carson JP; Robinson MW; Ramm GA; Gobert GN
Mol Biol Rep; 2021 Dec; 48(12):7677-7688. PubMed ID: 34648138
[TBL] [Abstract][Full Text] [Related]
10. Puerarin, isolated from Pueraria lobata (Willd.), protects against hepatotoxicity via specific inhibition of the TGF-β1/Smad signaling pathway, thereby leading to anti-fibrotic effect.
Xu L; Zheng N; He Q; Li R; Zhang K; Liang T
Phytomedicine; 2013 Oct; 20(13):1172-9. PubMed ID: 23856441
[TBL] [Abstract][Full Text] [Related]
11. PHP14 regulates hepatic stellate cells migration in liver fibrosis via mediating TGF-β1 signaling to PI3Kγ/AKT/Rac1 pathway.
Xu A; Li Y; Zhao W; Hou F; Li X; Sun L; Chen W; Yang A; Wu S; Zhang B; Yao J; Wang H; Huang J
J Mol Med (Berl); 2018 Feb; 96(2):119-133. PubMed ID: 29098317
[TBL] [Abstract][Full Text] [Related]
12. Asiatic acid inhibits liver fibrosis by blocking TGF-beta/Smad signaling in vivo and in vitro.
Tang LX; He RH; Yang G; Tan JJ; Zhou L; Meng XM; Huang XR; Lan HY
PLoS One; 2012; 7(2):e31350. PubMed ID: 22363627
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-497 induced by Clonorchis sinensis enhances the TGF-β/Smad signaling pathway to promote hepatic fibrosis by targeting Smad7.
Zhou QY; Yang HM; Liu JX; Xu N; Li J; Shen LP; Zhang YZ; Koda S; Zhang BB; Yu Q; Chen JX; Zheng KY; Yan C
Parasit Vectors; 2021 Sep; 14(1):472. PubMed ID: 34521449
[TBL] [Abstract][Full Text] [Related]
14. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.
Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F
Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586
[TBL] [Abstract][Full Text] [Related]
15. Periostin down-regulation attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-β1.
Hong L; Shejiao D; Fenrong C; Gang Z; Lei D
J Cell Mol Med; 2015 Oct; 19(10):2462-8. PubMed ID: 26249143
[TBL] [Abstract][Full Text] [Related]
16. GNS561, a new lysosomotropic small molecule, for the treatment of intrahepatic cholangiocarcinoma.
Brun S; Bassissi F; Serdjebi C; Novello M; Tracz J; Autelitano F; Guillemot M; Fabre P; Courcambeck J; Ansaldi C; Raymond E; Halfon P
Invest New Drugs; 2019 Dec; 37(6):1135-1145. PubMed ID: 30778887
[TBL] [Abstract][Full Text] [Related]
17. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH
Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496
[TBL] [Abstract][Full Text] [Related]
18. TGF-β1-elevated TRPM7 channel regulates collagen expression in hepatic stellate cells via TGF-β1/Smad pathway.
Fang L; Huang C; Meng X; Wu B; Ma T; Liu X; Zhu Q; Zhan S; Li J
Toxicol Appl Pharmacol; 2014 Oct; 280(2):335-44. PubMed ID: 25150141
[TBL] [Abstract][Full Text] [Related]
19. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
Wu C; Chen W; Ding H; Li D; Wen G; Zhang C; Lu W; Chen M; Yang Y
Life Sci; 2019 Dec; 239():116881. PubMed ID: 31678285
[TBL] [Abstract][Full Text] [Related]
20. ASPP2 Inhibits the Profibrotic Effects of Transforming Growth Factor-β1 in Hepatic Stellate Cells by Reducing Autophagy.
Lin M; Chang Y; Xie F; Shi Y; Pang L; Chen D
Dig Dis Sci; 2018 Jan; 63(1):146-154. PubMed ID: 29196956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]